Background Management of patients with classic lobular carcinoma in situ diagnosed on
core needle biopsy remains controversial, in part because of clinicopathologic overlap with …

According to the current World Health Organization classification of breast lesions, 1 lobular
neoplasia (LN) is defined as a term that encompasses the entire spectrum of atypical …

PURPOSE The clinical management of high-risk lesions using image-guided biopsy is
challenging. This study aimed to evaluate the rates at which such lesions were upgraded to …

OBJECTIVE. The practice of breast imaging in a collaborative multidisciplinary environment
adds significant value to outcomes in women's health care. In this article, we describe …

Background The core-needle biopsy (CNB) diagnosis of atypical ductal hyperplasia (ADH)
generally mandates follow-up excision, but controversy exists on whether small foci of ADH …

Lobular carcinoma in situ (LCIS) represents 5.3% of in situ specimens, and is thought to
carry a low risk for developing to the invasive lobular breast cancer (ILC). There is still no …

Objective To determine upgrade rates of lobular neoplasia (LN) to malignancy and evaluate
factors that may predict upgrade. Methods From 5/1/2003 to 12/30/2015, breast lesions …

Background The clinical significance of nonclassic, lobular carcinoma in situ (NC-LCIS) at
the surgical margin of excisions for invasive cancer is unknown. We sought to determine …

Aims Radial sclerosing lesions (RSLs) are benign breast lesions composed of glandular
and epithelial proliferations with stellate architecture and fibro‐elastotic stroma, which can …

Introduction: Atypical epithelial hyperplasia (AEH) of the breast is considered benign
histological lesions with breast cancer risk. This review focuses on clinical signification and …